Demuris is focused on the discovery of new antibiotics that will combat the threat from emerging diseases and the rise of antibiotic resistance. A portfolio of innovative assays is being used to screen for inhibitors that act differently from existing antibiotics. Demuris also provides the opportunity to discover and develop small molecule inhibitors against a range of interesting drug targets, together with the medicinal chemistry expertise needed to add value by making the initial inhibitors more drug-like. The overall output of the Demuris discovery engine will cover a strong intellectual property portfolio for out-licensing to pharmaceutical and biotechnology companies.
Company Details
- Address
- The Biosphere, Newcastle Upon Tyne,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.demuris.co.uk
- Keywords
- McLean.
- HQ
- Newcastle upon Tyne
Demuris Ltd Questions
Demuris Ltd's website is http://www.demuris.co.uk
Demuris Ltd's LinkedIn profile is https://uk.linkedin.com/company/demuris-ltd
Demuris Ltd's industry is
Pharmaceutical Manufacturing
Demuris Ltd's top competitors are
Nihr Newcastle Biomedical Research Centre (Brc),
Purpose,
Full Circle Microbes, Inc.,
Nuvionx Ltd,
Nova Biomedical Uk,
Halcyon Genetics,
Ugendx Limited,
Total Resources (Uk) Ltd,
Odyssey Therapeutics,
Melatech.
Demuris Ltd's categories are Pharmaceutical Manufacturing
